GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,873,000 | -3.6% | 43,031 | -3.5% | 0.41% | -5.1% |
| Q1 2022 | $1,942,000 | -1.3% | 44,592 | 0.0% | 0.43% | -2.3% |
| Q4 2021 | $1,967,000 | +55.6% | 44,592 | +34.8% | 0.44% | +30.6% |
| Q3 2021 | $1,264,000 | +181.5% | 33,091 | +193.2% | 0.34% | +198.2% |
| Q2 2021 | $449,000 | +11.4% | 11,286 | 0.0% | 0.11% | +0.9% |
| Q1 2021 | $403,000 | +2.5% | 11,286 | +5.6% | 0.11% | +7.6% |
| Q4 2020 | $393,000 | -20.9% | 10,690 | -19.1% | 0.10% | -39.3% |
| Q3 2020 | $497,000 | -38.3% | 13,206 | -33.2% | 0.17% | -46.3% |
| Q2 2020 | $806,000 | -16.9% | 19,755 | -22.8% | 0.32% | -44.9% |
| Q1 2020 | $970,000 | -10.6% | 25,600 | +10.8% | 0.58% | -6.7% |
| Q4 2019 | $1,085,000 | +28.6% | 23,100 | +16.8% | 0.63% | +22.3% |
| Q3 2019 | $844,000 | – | 19,770 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |